AnalystBook Research · Company Intelligence

UNILEVER PLC

ULNYSE

Built from UNILEVER PLC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Turnover fell 3.8% to €50.50B on currency; net income of €9.47B includes a €3,373m gain on demerging the Ice Cream business.

The read at a glance✓ Audited against SEC data
  • Growth — Turnover -3.8% to €50.50B, cut by currencyWatch
  • Profitability — Operating margin 17.9%, up 107 bpsOK
  • One-off — Net income €9.47B includes €3,787m from the demerged Ice Cream businessWatch
  • Cash — Free cash flow €6.93B, -14.8%Watch
  • Accounting — No manipulation flag; earnings quality safeOK
  • Capital — €6.0bn returned: €4.5bn dividends and €1.5bn buybacksNote

Business

Unilever sells consumer brands in four Business Groups: Beauty & Wellbeing, Personal Care, Home Care and Foods. It demerged its Ice Cream business on 6 December 2025, so figures are shown for the continuing company, with prior years re-presented where the company has done so.

Latest filings

  • 6-K · Company announcement (foreign filer)2026-09-25
  • 6-K · Company announcement (foreign filer)2026-09-24
  • 6-K · Company announcement (foreign filer)2026-09-01
  • 6-K · Company announcement (foreign filer)2026-08-24
  • 6-K · Company announcement (foreign filer)2026-08-03
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about UNILEVER PLC, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.